LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE SCLERODERMA FOUNDATION OF CALIFORNIA, founded in 1989, is a small nonprofit in the Diseases & Disorders sector that reported $275K in total revenue in fiscal year 2023. Expenses of $337K exceeded revenue, resulting in a 23% operating deficit.
EMPOWERING THE SCLERODERMA COMMUNITY TO LIVE BETTER LIVES THROUGH PROGRAMS COMMITTED TO SUPPORT, EDUCATION, AND RESEARCH.PILLARS OF OUR MISSION: SUPPORT: INSPIRING OUR COMMUNITY THROUGH PATIENT SUPPORT SERVICES AND RESOURCES FOR PATIENTS INCLUDING 26 VOLUNTEER DRIVEN LOCAL COMMUNITY & PEER LED SUPPORT GROUPS, STAFF DRIVEN ONE-ON-ONE PROFESSIONAL GUIDANCE THAT ALLOWS THEM TO THRIVE. EDUCATION: FOR MEDICAL PROFESSIONALS TO HELP THEM UNDERSTAND AND PROPERLY DIAGNOSIS SCLERODERMA EARLY, AND FOR PATIENTS TO HELP THEM AND COPE AND THRIVE WHILE LIVING WITH SCLERODERMA. RESEARCH: FUNDING RESEARCH PROJECTS THAT WILL LEAD THE WAY TO FINDING A CURE FOR SCLERODERMA.
SUPPORT: PROVIDE PATIENT SUPPORT AND EDUCATION TO OVER 1000 PATIENTS AFFECTED BY SCLERODERMA IN CALIFORNIA WE WORK TO BUILD OVERALL AWARENESS OF THE DISEASE. THE FOUNDATION NOW HAS 26 COMMUNITY...
SUPPORT: PROVIDE PATIENT SUPPORT AND EDUCATION TO OVER 1000 PATIENTS AFFECTED BY SCLERODERMA IN CALIFORNIA WE WORK TO BUILD OVERALL AWARENESS OF THE DISEASE. THE FOUNDATION NOW HAS 26 COMMUNITY SUPPORT GROUPS. MOST GROUPS MEET BI-MONTHLY AND HAVE AN AVERAGE ATTENDANCE OF 25-20 PEOPLE. IN 2023 MANY OF OUR SUPPORT GROUPS TRANSITIONED BACK TO IN-PERSON MEETINGS AND WE WERE ABLE TO GROW TO REACH APPROXIMATELY 2000+ PATIENTS/CAREGIVERS AND FAMILY MEMBERS. WE WILL CONTINUE TO PROVIDE ONLINE MEETINGS AS WELL AS IN-PERSON MEETINGS. SUPPORT GROUPS PROVIDE A FORUM TO SHARE FEELINGS, CONCERNS, INFORMATION, AS WELL AS A PLACE TO OFFER PEER SUPPORT AND ENCOURAGEMENT. SOLICITATIONS OR RESEARCH PROJECTS ARE NOT CONDUCTED AT SUPPORT GROUP MEETINGS. SUPPORT GROUPS OFTEN FEATURE SPEAKERS SPECIALIZING IN SCLERODERMA OR RELATED TOPICS. ALL SUPPORT GROUPS ARE FREE OF CHARGE AND OPEN TO EVERYONE, INCLUDING PATIENTS, CAREGIVERS, FAMILY AND FRIENDS.
EDUCATION:IN 2023 THE SCLERODERMA FOUNDATION HOSTED AN ONLINE EDUCATION EVENT FOR PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE TOTAL NUMBER WHO BENEFITTED APPROXIMATELY 500.FOR MEDICAL...
EDUCATION:IN 2023 THE SCLERODERMA FOUNDATION HOSTED AN ONLINE EDUCATION EVENT FOR PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE TOTAL NUMBER WHO BENEFITTED APPROXIMATELY 500.FOR MEDICAL PROFESSIONALS TO HELP THEM UNDERSTAND AND PROPERLY DIAGNOSIS SCLERODERMA EARLY, AND FOR PATIENTS TO HELP THEM AND COPE AND THRIVE WHILE LIVING WITH SCLERODERMA.
RESEARCH:WE CONTINUE TO SEEK RESEARCH PROJECTS TO FUND TO FIND A CURE TO END SCLERODERMA.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $274,776 | $277,045 | 0.0% |
| Expenses | $336,901 | $286,980 | +0.2% |
| Net Income | $-62,125 | $-9,935 | +5.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DR DAN FURST | ACTING PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID PARKER | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| LAURA FUHRMAN | VICE PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARIA SALINAS | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| PEGGY HICKMAN | PAST PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| CHRIS PETTIT | VICE PRESIDENT | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| ALINA AGENA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOEL CHERMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRIS CORMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEPHEN ELROD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHARON FRIEDMAN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHERVIN GHANOONGOOI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KRISTY KUBOTA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSAN NYANZI | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MARTHA SOTO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LES WOOD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREW EMMETT | EXECUTIVE DIRECTOR | 45.00 |
Officer
|
$114,019 | $7,472 | $121,491 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $274,776 | $336,901 | $298,863 | $-62,125 |
| 2022 | $277,045 | $286,980 | $365,330 | $-9,935 |
| 2021 | $422,594 | $328,751 | $388,498 | $93,843 |
| 2020 | $311,085 | $373,826 | $328,101 | $-62,741 |
| 2019 | $355,071 | $446,418 | $392,338 | $-91,347 |
| 2018 | $370,265 | $400,435 | $510,706 | $-30,170 |
Compare THE SCLERODERMA FOUNDATION OF CALIFORNIA with other nonprofits in California and across the country.